Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02812212 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Study acronym: JUMP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jun 2019 to Nov 2026
    • Start date: Jun 2017 to Nov 28, 2017
    • Study sites: 1 to 5
    • Study completion date: Jun 2020 to Apr 2027
  2. Primary completion date: Sep 2018 to Jun 2019
    • Start date: Sep 2016 to Jun 2017
    • Study completion date: Sep 2019 to Jun 2020
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome
Trial Details
NCT Number NCT02812212
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions
(from sponsor)		 Ureteropelvic Junction Obstruction
Related terms Multicystic renal dysplasia, bilateral
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov